Literature DB >> 1723886

Effect of selenium compounds and thiols on human mammary tumor cells.

L Yan1, J A Yee, L M Boylan, J E Spallholz.   

Abstract

The effect on cell viability and growth rate of sodium selenite, selenocystine, sodium selenate, and selenomethionine at selenium concentrations of 6.25 and 12.5 uM was studied in vitro on cells of the human mammary tumor cell line HTB123/DU4475. Selenite and selenocystine affected both cell viability and growth rate of the tumor cells at these selenium concentrations. Selenite and selenocystine decreased intracellular glutathione concentrations, but did not affect tumor cell glutathione peroxidase activity. After six days of exposure to either selenate or selenomethionine, the viability of tumor cells remained stable, but cell growth, as measured by numbers of cells, was retarded. Neither selenate nor selenomethionine produced changes in concentrations of intracellular glutathione. The toxic effect of selenite on tumor cells was enhanced by addition of 0.25 mM glutathione to the growth medium. Preincubation of the tumor cells with 62.5 uM buthionine sulfoximine decreased cellular glutathione to 15% of controls at 24 h and enhanced the toxicity of selenite toward the tumor cells. Glutathione, 2-mercaptoethanol, and L-cysteine were all toxic to the tumor cells in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723886     DOI: 10.1007/bf02990350

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  33 in total

1.  Catalytic oxidation of glutathione and other sulfhydryl compounds by selenite.

Authors:  C C TSEN; A L TAPPEL
Journal:  J Biol Chem       Date:  1958-11       Impact factor: 5.157

2.  Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase.

Authors:  H E Ganther
Journal:  Biochemistry       Date:  1971-10-26       Impact factor: 3.162

3.  Selenotrisulfides. Formation by the reaction of thiols with selenious acid.

Authors:  H E Ganther
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

4.  Mechanisms of selenium inhibition of tumorigenesis.

Authors:  D Medina
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

5.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

6.  Involvement of cellular sulfhydryl compounds in the inhibition of RNA synthesis by selenite.

Authors:  G D Frenkel; D Falvey
Journal:  Biochem Pharmacol       Date:  1989-09-01       Impact factor: 5.858

7.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

8.  Activation of selenate by adenosine 5'-triphosphate sulphurylase from Saccharomyces cerevisiae.

Authors:  G L Dilworth; R S Bandurski
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

9.  Factors influencing the antitumorigenic properties of selenium in mice.

Authors:  K A Poirier; J A Milner
Journal:  J Nutr       Date:  1983-11       Impact factor: 4.798

10.  Involvement of glutathione reductase in selenite metabolism and toxicity, studied in isolated rat hepatocytes.

Authors:  I Anundi; J Högberg; A Ståhl
Journal:  Arch Toxicol       Date:  1982-07       Impact factor: 5.153

View more
  4 in total

1.  Responses of an American eel brain endothelial-like cell line to selenium deprivation and to selenite, selenate, and selenomethionine additions in different exposure media.

Authors:  Sophia R Bloch; John J Kim; Phuc H Pham; Peter V Hodson; Lucy E J Lee; Niels C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-09-22       Impact factor: 2.416

2.  Effect of selenium compounds on murine B16 melanoma cells and pigmented cloned pB16 cells.

Authors:  B Siwek; E Bahbouth; M A Serra; E Sabbioni; M C de Pauw-Gillet; R Bassleer
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer.

Authors:  Soni Khandelwal; Mallory Boylan; Gilbert Kirsch; Julian E Spallholz; Lauren S Gollahon
Journal:  Antioxidants (Basel)       Date:  2020-02-05

4.  Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells.

Authors:  Soni Khandelwal; Mallory Boylan; Julian E Spallholz; Lauren Gollahon
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.